New Key Statistics Module, Z-Score and F-Score
NSE:NATCOPHARM Key Ratios
Market Cap ₹ M | 182,781.62 |
Enterprise Value ₹ M | 173,100.62 |
P/E(ttm) | 14.41 |
PE Ratio without NRI | 14.41 |
Forward PE Ratio | -- |
Price/Book | 3.45 |
Price/Sales | 4.82 |
Price/Free Cash Flow | 28.95 |
Price/Owner Earnings | 29.24 |
Payout Ratio % | 0.13 |
Revenue (TTM) ₹ M | 38,182.00 |
EPS (TTM) ₹ | 70.84 |
Beneish M-Score | -2.33 |
10-y EBITDA Growth Rate % | 15.80 |
5-y EBITDA Growth Rate % | -7.00 |
y-y EBITDA Growth Rate % | 160.20 |
EV-to-EBIT | 11.31 |
EV-to-EBITDA | 10.16 |
PEG | -- |
Shares Outstanding M | 179.11 |
Net Margin (%) | 33.47 |
Operating Margin % | 37.69 |
Pre-tax Margin (%) | 39.82 |
Quick Ratio | 3.01 |
Current Ratio | 3.81 |
ROA % (ttm) | 22.56 |
ROE % (ttm) | 26.01 |
ROIC % (ttm) | 28.45 |
Dividend Yield % | 0.93 |
Altman Z-Score | 13.31 |
NSE:NATCOPHARM Number of Guru Trades
NSE:NATCOPHARM Volume of Guru Trades
Gurus Latest Trades with NSE:NATCOPHARM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NSE:NATCOPHARM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data